Total Funding
9
63
Total FundingSeries A raised
Growth Score 9 in past quarter
-32 pts
Heat Score 63 in past quarter
5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
MRL Ventures is Merck’s independent early-stage therapeutics venture capital fund.
Reza Halse: PartnerPast Role: Partners Innovation Fund, Partner- Olga Danilchanka: Partner

Merck
About the Company
The MRL Venture Fund is the Cambridge, MA – based independent venture capital investment group within Merck Research Laboratories, the R&D division of Merck & Co., Inc. MRL Ventures creates and/or invests in seed and early-stage therapeutics companies, based on translatable breakthrough science, with the potential to deliver highly
differentiated new medicines to improve human health.

